GlobalData on MSN

Viz.ai and Alnylam to advance earlier identification of cardiac amyloidosis

The partnership will see Viz.ai develop an AI Care Pathway for cardiac amyloidosis.

PPMD Provides $250,000 in Funding to Secretome Therapeutics Through PPMD Venture Pathways Program to Support Development of Cardiac Cell Therapy

Parent Project Muscular Dystrophy (PPMD), the leading U.S. non-profit driving Duchenne and Becker muscular dystrophy care, research, and advocacy efforts, and Secretome Therapeutics (Secretome) are ...
TCTMD

High-Sensitivity Troponins Improve HEART Pathway in Chest Pain Workup

Incorporating high-sensitivity cardiac troponin (hs-cTn) testing into the traditional HEART pathway may improve detection of acute MI in patients presenting to the emergency department (ED) with chest ...
EurekAlert!

Researchers target proteins, pathways behind congenital heart disease

CHAPEL HILL, N.C. – Researchers at the UNC School of Medicine, UNC McAllister Heart Institute, and the UNC Lineberger Comprehensive Cancer Center characterized the expression of thousands of cardiac ...
Science Daily

Study finds two protein pathways downregulated in postnatal heart

Researchers discovered two signaling pathways that are downregulated in human hearts after birth. Published today in Stem Cell Reports, researchers from the University of Minnesota Medical School ...

Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care Coordination in Cardiac Amyloidosis

Viz.ai, the leader in AI-powered disease detection and care coordination, today announced a partnership with Alnylam ...